Şirket bioteknoloji alanındaki çeyreklik sonuçlarını açıkladığı sırada, finansal durumu hakkında bir güncelleme de yaptı.
Cantargia released its Q2 2026 earnings results, reporting a loss for the quarter. The company also noted an improvement in its cash runway during the period.
Weitere verifizierbare details über den verlustbetrag oder operationelle Einzelheiten waren sofort nicht verfügbar.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Más de Priya Anand →
